𝔖 Bobbio Scriptorium

✦ LIBER ✦

Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-centre study

✍ Scribed by Nazar N. Amso; Seth A. Stabinsky; Peter McFaul; Bernard Blanc; Laura Pendley; Robert Neuwirth

Book ID: 111158443
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 736 KB
Volume: 105
Category: Article
ISSN: 1470-0328
DOI: 10.1111/j.1471-0528.1998.tb10152.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Uterine endometrial thermal balloon ther

Uterine endometrial thermal balloon therapy for the treatment of menorrhagia: Long-term multicenter follow-up study

✍ NN Amso 📂 Article 📅 2003 🏛 American Association of Gynecologic Laparoscopists 🌐 English ⚖ 118 KB

86 A prospective study for the treatment

86 A prospective study for the treatment of stress urinary incontinence arising from intrinsic sphincter deficiency with ACT™ balloons (adjustable continence therapy)

✍ E. CHARTIER KASTLER; V. CARDOT; P. MOZER; L. BASTIEN; F. RICHARD; P. DENYS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Assessment of the effect of ramipril the

Assessment of the effect of ramipril therapy on direct health care costs for first and recurrent strokes in high-risk cardiovascular patients using data from the heart outcomes prevention evaluation (HOPE) study

✍ Cathryn A. Carroll; Michael M. Coen; Marilyn M. Rymer 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 729 KB

682: 1-Year Results of the First 120 Pat

682: 1-Year Results of the First 120 Patients Enrolled in a 3-Year Randomised, Open Label, Multi-Centre Investigator Driven Study Comparing De Novo Enteric Coated Mycophenolate Sodium with Delayed Onset Everolimus, Both Arms in Combination with Cyclosporin (Using C2 Monitoring) and Corticosteroids for the Prevention of Bronchiolitis Obliterans Syndrome in Heart-Lung, Bilateral Lung and Single Lung Transplant Recipients

✍ A.R. Glanville; C. Aboyoun; W. Klepetko; H. Reichenspurner; H. Treede; E. Versch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB